Takeda Pharmaceutical (TAK) Short-Term Debt issuances (2018 - 2020)
Historic Short-Term Debt issuances for Takeda Pharmaceutical (TAK) over the last 3 years, with Q1 2020 value amounting to -$238.6 million.
- Takeda Pharmaceutical's Short-Term Debt issuances fell 10714.21% to -$238.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$3.2 billion, marking a year-over-year decrease of 19510.04%. This contributed to the annual value of -$3.2 billion for FY2020, which is 19685.08% down from last year.
- Takeda Pharmaceutical's Short-Term Debt issuances amounted to -$238.6 million in Q1 2020, which was down 10714.21% from $1.3 billion recorded in Q4 2019.
- Takeda Pharmaceutical's Short-Term Debt issuances' 5-year high stood at $3.3 billion during Q1 2019, with a 5-year trough of -$4.5 billion in Q2 2019.
- For the 3-year period, Takeda Pharmaceutical's Short-Term Debt issuances averaged around $20.4 million, with its median value being -$991630.9 (2018).
- Examining YoY changes over the last 5 years, Takeda Pharmaceutical's Short-Term Debt issuances showed a top increase of 9889662.02% in 2019 and a maximum decrease of 63568084.08% in 2019.
- Over the past 3 years, Takeda Pharmaceutical's Short-Term Debt issuances (Quarter) stood at -$1.3 million in 2018, then soared by 98896.62% to $1.3 billion in 2019, then tumbled by 119.05% to -$238.6 million in 2020.
- Its Short-Term Debt issuances was -$238.6 million in Q1 2020, compared to $1.3 billion in Q4 2019 and $361.5 million in Q3 2019.